Comprehensive Oncology Review

This four-day intensive, comprehensive review will incorporate data supporting guideline-based recommendations and recent advances regarding the management of patients with malignant hematologic and solid tumor disorders. Attendees will have the opportunity to participate in case-based review sessions and discussions and will have access to a comprehensive syllabus and self-assessment materials.